Nivolumab

ATC L01FF01

articles: 2
regulatory signals: 0
cases: 0

Articles on nivolumab

Review 05.11.2026

Pembrolizumab in laryngeal and pharyngeal tumors: partial and complete regression in two clinical cases

Consider the potential role of immunotherapy in multidisciplinary treatment planning for laryngeal and pharyngeal tumors. The authors emphasize assessing PD-L1 expression using CPS for patient selection.

#nivolumab #pembrolizumab clinicaloncology.com.ua

Review 05.11.2026

Selpercatinib and other perioperative strategies in localized non-small cell lung cancer

The review emphasizes molecular profiling to guide perioperative strategies in non-small cell lung cancer and highlights the potential of neoadjuvant approaches in selected patients.

#erlotinib #lorlatinib #nivolumab #osimertinib #selpercatinib d8miq7k9f04rm.cloudfront.net

Interactions mentioned in the articles

Erlotinib
Lorlatinib
Osimertinib
Pembrolizumab
Selpercatinib

Digest for physicians

Subscribe to be among the first to get the digest when we launch it.

Similar substances

Pembrolizumab 2 articles
Rituximab 2 articles
Daratumumab 1 article